1,778
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague–Dawley rats

, , , , , & show all
Pages 1596-1605 | Received 20 Jan 2015, Accepted 10 Oct 2015, Published online: 21 Jan 2016

References

  • Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. 2013. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 105:1907–1911.
  • Berggren AM, Björck IME, Nyman EMGL, Eggum BO. 1993. Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates. J Sci Food Agric. 63:397–406.
  • Bird RP. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:147–151.
  • Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. 2014. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 20:859–867.
  • Boren J, Lee WN, Bassilian S, Centelles JJ, Lim S, Ahmed S, Boros LG, Cascante M. 2003. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem. 278:28395–28402.
  • Burns AJ, Rowland IR. 2000. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol. 1:13–24.
  • Callaway TR, Edrington TS, Harvey RB, Anderson RC, Nisbet DJ. 2012. Prebiotics in food animals, a potential to reduce foodborne pathogens and disease. Rom Biotech Lett. 17:7808–7816.
  • Campbell JM, Fahey GC Jr, Wolf BW. 1997. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr. 127:130–136.
  • Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, De Smet R, Vanholder R, Dignat-George F, Sampol J, et al. 2004. P-Cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost. 92:140–150.
  • Challa A, Rao DR, Chawan CB, Shackelford L. 1997. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18:517–521.
  • Comalada M, Bailón E, de Haro O, Lara-Villoslada F, Xaus J, Zarzuelo A, Gálvez J. 2006. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol. 132:487–497.
  • Danilcenko H, Jarienė E, Aleknaviciene P. 2008. Quality of Jerusalem artichoke (Helianthus tuberosus L.) tubers in relation to storage conditions. Not Bot Hort Agrobot Cluj. 36:23–27.
  • de Morenode LeBlanc A, Perdigon G. 2005. Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29:15–24.
  • De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, Verbeke K. 2007. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol. 292:G358–G368.
  • Deeptha K, Kamaleeswari M, Sengottuvelan M, Nalini N. 2006. Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Invest New Drugs 24:479–488.
  • Duan H, Heckman CA, Boxer LM. 2005. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol. 25:1608–1619.
  • Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23:1953–1960.
  • Fung KY, Brierley GV, Henderson S, Hoffmann P, McColl SR, Lockett T, Head R, Cosgrove L. 2011. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. J Proteome Res. 10:1860–1869.
  • Geng J, Fan H, Tang X, Zhai H, Zhang Z. 2013. Diversified pattern of the human colorectal cancer microbiome. Gut Pathog. 5:2.
  • Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 125:1401–1412.
  • Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, et al. 2010. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods 7:1–19.
  • Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. 1994. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 54:2390–2397.
  • Gorbach SL, Goldin BR. 1990. The intestinal microflora and the colon cancer connection. Rev Infect Dis. 12:S252–S261.
  • Guinane CM, Cotter PD. 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 6:295–308.
  • Haberer P, du Toit M, Dicks LM, Ahrens F, Holzapfel WH. 2003. Effect of potentially probiotic lactobacilli on faecal enzyme activity in minipigs on a high-fat, high-cholesterol diet-a preliminary in vivo trial. Int J Food Microbiol. 87:287–291.
  • Henningsson A, Bjorck I, Nyman M. 2001. Short-chain fatty acid formation at fermentation of indigestible carbohydrates. Scand J Nutr. 45:165–168.
  • Hijova E, Chmelarova A. 2007. Short chain fatty acids and colonic health. Bratisl Lek Listy 108:354–358.
  • Hijova E, Szabadosova V, Strojny L, Bomba A. 2014. Changes chemopreventive markers in colorectal cancer development after inulin supplementation. Bratisl Lek Listy 115:76–79.
  • Hirschhaeuser F, Sattler UG, Mueller-Klieser W. 2011. Lactate: a metabolic key player in cancer. Cancer Res. 71:6921–6925.
  • Hughes R, Magee EA, Bingham S. 2000. Protein degradation in the large intestine: relevance to colorectal cancer. Curr Issues Intest Microbiol. 1:51–58.
  • Hughes R, Rowland IR. 2000. Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health D 12:179–185.
  • Khuhaprema T, Sangrajrang S, Lalitwongsa S, Chokvanitphong V, Raunroadroong T, Ratanachu-Ek T, Muwonge R, Lucas E, Wild C, Sankaranarayanan R. 2014. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open 4:e003671.
  • Khuhaprema T, Srivatanakul P. 2008. Colon and rectum cancer in Thailand: an overview. Jpn J Clin Oncol. 38:237–243.
  • Kirjavainen PV, Arvola T, Salminen SJ, Isolauri E. 2002. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51:51–55.
  • Larsson SC, Wolk A. 2006. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 119:2657–2664.
  • Lee SM, Lee WK. 2001. Effects of lactic acid bacteria on intestinal microbial enzyme activity and composition in rats treated with azoxymethane. J Microbiol. 39:154–161.
  • Lima ES, Abdalla DSP. 2002. High-performance liquid chromatography of fatty acids in biological samples. Anal Chim Acta. 465:81–91.
  • Loh G, Eberhard M, Brunner RM, Hennig U, Kuhla S, Kleessen B, Metges CC. 2006. Inulin alters the intestinal microbiota and short-chain fatty acid concentrations in growing pigs regardless of their basal diet. J Nutr. 136:1198–1202.
  • Mager DL. 2006. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 4:14. DOI: 10.1186/1479-5876-4-14.
  • McCall IC, Betanzos A, Weber DA, Nava P, Miller GW, Parkos CA. 2009. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol. 241:61–70.
  • Nagengast F, Grubben M, van Munster I. 1995. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31:1067–1070.
  • Niness KR. 1999. Inulin and oligofructose: what are they? J Nutr. 129:1402S–1406S.
  • Nowak A, Libudzisz Z. 2006. Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria. Anaerobe 12:80–84.
  • Nowak A, Libudzisz Z. 2007. Ability of intestinal lactic bacteria to bind or/and metabolize phenol and p-cresol. Ann Microbiol. 57:329–335.
  • Pan X, Chen F, Wu T, Tang H, Zhao Z. 2009. Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. J Zhejiang Univ Sci B. 10:258–263.
  • Pang T, Leach ST, Katz T, Day AS, Ooi CY. 2014. Fecal biomarkers of intestinal health and disease in children. Front Pediatr. 2:6. doi:10.3389/fped.2014.00006
  • Pattananandecha T, Sirilun S, Sivamaruthi BS, Suwannalert P, Sartjin Peerajan S, Chaiyasut C. 2015. Hydrolyzed inulin with different degree of polymerization as prebiotic for Lactobacillus plantarum. J Pure Appl Microbiol. 9:973–979.
  • Propst EL, Flickinger EA, Bauer LL, Merchen NR, Fahey GC Jr. 2003. A dose–response experiment evaluating the effects of oligofructose and inulin on nutrient digestibility, stool quality, and fecal protein catabolites in healthy adult dogs. J Anim Sci. 81:3057–3066.
  • Rafii F, Franklin W, Cerniglia CE. 1990. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl Environ Microbiol. 56:2146–2151.
  • Reddy B, Hamid R, Rao CV. 1997. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18:1371–1374.
  • Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, Matteuzzi D. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol. 71:6150–6158.
  • Rowland IR, Rumney CJ, Coutts JT, Lievense LC. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281–285.
  • Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94–100.
  • Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG Jr. 1980. Absorption of short-chain fatty acids by the colon. Gastroenterology 78:1500–1507.
  • Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046–1049.
  • Sandhu MS, White IR, Mc Pherson K. 2001. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev. 10:439–446.
  • Schwabe RF, Jobin C. 2013. The microbiome and cancer. Nat Rev Cancer 13:800–802.
  • Siavoshian S, Segain J, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, Blottière HM. 2000. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46:507–514.
  • Slavin J. 2013. Fiber and prebiotics: mechanisms and health benefits. Nutrients 5:1417–1435.
  • Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Healy HP, Dawson KA, Merchen NR, Fahey GC Jr. 2002. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. J Nutr. 132:980–989.
  • Topping D, Clifton P. 2001. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 81:1031–1064.
  • Uccello M, Malaguarnera G, Basile F, D’agata V, Malaguarnera M, Bertino G, Vacante M, Drago F, Biondi A. 2012. Potential role of probiotics on colorectal cancer prevention. BMC Surg. 12:S35.
  • Vande Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. 2007. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 102:452–460.
  • Van Loo J. 2004. The specificity of the interaction with intestinal bacterial fermentation by prebiotics determines their physiological efficacy. Nutr Res Rev. 17:89–98.
  • Van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr. 35:525–552.
  • Verghese M, Rao DR, Chawan CB, Shackelford L. 2002a. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr. 132:2804–2808.
  • Verghese M, Rao DR, Chawan CB, Williams LL, Shackelford L. 2002b. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. J Nutr. 132:2809–2813.
  • Verghese M, Walker LT, Shackelford L, Chawan CB. 2005. Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats. Nutr Res. 25:859–868.
  • Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. 2008. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem. 19:587–593.
  • Whitlock K, Gill RS, Birch DW, Karmali S. 2012. The association between obesity and colorectal cancer. Gastroenterol Res Pract. 2012:1–6.
  • Windey K, De Preter V, Verbeke K. 2012. Relevance of protein fermentation to gut health. Mol Nutr Food Res 56:184–196.
  • Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. 2006. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 40:235–243.
  • Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD. 2014. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila). 7:1112–1121.
  • Zhang X, Ohta Y. 1993. Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat Res. 298:247–253.
  • Zhao Y, Hasjim J, Li L, Jane JL, Hendrich S, Birt DF. 2011. Inhibition of azoxymethane-induced preneoplastic lesions in the rat colon by a cooked stearic acid complexed high-amylose cornstarch. J Agric Food Chem. 59:9700–9708.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.